Home - Products - Others - Other Targets - 2,2-Di(4-tert-octylphenyl)-1-picrylhydrazyl free radical

2,2-Di(4-tert-octylphenyl)-1-picrylhydrazyl free radical

CAS No. 84077-81-6

2,2-Di(4-tert-octylphenyl)-1-picrylhydrazyl free radical( ——— )

Catalog No. M38642 CAS No. 84077-81-6

2,2-Di(4-tert-octylphenyl)-1-picrylhydrazyl free radical

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    2,2-Di(4-tert-octylphenyl)-1-picrylhydrazyl free radical
  • Note
    Research use only, not for human use.
  • Brief Description
    2,2-Di(4-tert-octylphenyl)-1-picrylhydrazyl free radical
  • Description
    2,2-Di(4-tert-octylphenyl)-1-picrylhydrazyl free radical
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    84077-81-6
  • Formula Weight
    618.74
  • Molecular Formula
    C34H44N5O6
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Nirmatrelvir

    PF-07321332 is a potent and orally active inhibitor of SARS-CoV 3C-like protease (3CLPRO) .

  • 5-Hydroxymethyl-2-fu...

    5-Hydroxymethyl-2-furancarboxylic acid (Sumiki's acid) is a naturally occurring human metabolite. Sumiki's acid was first identified in the urine of a leukemia patient who was excreting an abnormal amount of its glycine derivative. Sumiki's acid has been found to be a byproduct of the fungus Aspergillus and probably other species of fungi and yeast as well.

  • 4-Methoxycoumarine

    4-Methoxycoumarine has antitumour effects.Coumarin has antitumour effects in vivo and cytostatic effects in vitro. Its half-life in humans is short (1-1.5 h) and the monohydroxylated biotransformation products have significantly longer half-lives.